Sacituzumab govitecan failed to extend PFS in patients with hormone receptor-positive, HER2-negative breast cancer following ...

In this video from the American Academy of Ophthalmology meeting, Michael W. Stewart, MD, discussed results from the phase 2 ...

An AI-driven language module showed promise in capturing and structuring patient history, according to a case study presented ...

Presence of uterine fibroids was associated with increased risk for atherosclerotic heart disease compared with absence of ...

A novel triple receptor agonist conferred weight loss of up to 28.7% at 68 weeks and reductions in pain for adults with ...

In this Healio Video Perspective from the American Academy of Ophthalmology meeting, Jai G. Parekh, MD, MBA, discusses the ...

The novel drug atacicept was associated with significant reductions in proteinuria vs. placebo with comparable safety and no ...

Rocatinlimab improved moderate to severe dermatitis in adults, establishing the OX40 receptor as a validated treatment target ...

In this video, Crystal A. Gadegbeku, MD, FASN, discusses some of the late-breaking clinical trials in broad and specific kidney disease treatments presented at ASN Kidney Week.“We are really in an era ...

Around 88% of primary care providers managing patients with uncontrolled asthma reported being unfamiliar or only somewhat familiar with biologic therapy, according to survey findings.These data were ...

At this year’s American College of Allergy, Asthma & Immunology Scientific Meeting, Anne K. Ellis, MD, MSc, FACAAI, received ...

Approximately 43% of patients aged 65 years or older with rheumatic disease filled at least one opioid prescription in 2021, ...